Long G. Wang
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- Toxicology top 10%
Papers in
-
- DNA Repair Mechanisms 1
- Epigenetics and DNA Methylation 1
- FOXO transcription factor regulation 1
- Cancer therapeutics and mechanisms 1
-
- Prostate Cancer Treatment and Research 6
- Co-authors
- Willi Kreis (6 shared papers)Daniel R. Budman (5 shared papers)Anna C. Ferrari (3 shared papers)Liliana Ossowski (2 shared papers)D. R. Budman (1 shared paper)Laurel M. Adams (1 shared paper)Anthony Calabro (1 shared paper)David Zhang (1 shared paper)
- Journals
- Biochemical Pharmacology (3 papers)Clinical Cancer Research (1 paper)Cancer Investigation (1 paper)European Journal of Immunology (1 paper)ImmunoTargets and Therapy (1 paper)
- Partner nations
- United StatesFranceChina
In The Last Decade
Long G. Wang
15 papers receiving 857 citations
Peers
Comparison fields: 5 of 94
- Oncology 221
- Toxicology 28
- Molecular Biology 466
- Cell Biology 98
- Pulmonary and Respiratory Medicine 175
Countries citing papers authored by Long G. Wang
This map shows the geographic impact of Long G. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long G. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long G. Wang more than expected).
Fields of papers citing papers by Long G. Wang
This network shows the impact of papers produced by Long G. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long G. Wang. The network helps show where Long G. Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Long G. Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 329 | |
| 2 | 2005 | 153 | |
| 3 | Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells. | 1997 | 62 |
| 4 | Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. | 2001 | 54 |
| 5 | 1999 | 43 | |
| 6 | 2004 | 42 | |
| 7 | 1996 | 42 | |
| 8 | 2000 | 35 | |
| 9 | 2006 | 35 | |
| 10 | 2011 | 31 | |
| 11 | 1998 | 18 | |
| 12 | Mithramycin targets sp1 and the androgen receptor transcription level-potential therapeutic role in advanced prostate cancer. | 2006 | 16 |
| 13 | 2010 | 12 | |
| 14 | 1999 | 8 | |
| 15 | 2022 | 3 |
About Long G. Wang
Long G. Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Genetics and Neurology, having authored 15 papers that have together received 883 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Estrogen and related hormone effects (4 papers), Hormonal and reproductive studies (3 papers), DNA Repair Mechanisms (1 paper), Epigenetics and DNA Methylation (1 paper), FOXO transcription factor regulation (1 paper), T-cell and B-cell Immunology (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (221 citations), Toxicology (28 citations), Molecular Biology (466 citations), Cell Biology (98 citations) and Pulmonary and Respiratory Medicine (175 citations). Long G. Wang has collaborated with scholars based in United States, France and China. Frequent co-authors include Willi Kreis, Daniel R. Budman, Anna C. Ferrari, Liliana Ossowski, D. R. Budman, Laurel M. Adams, Anthony Calabro, David Zhang, Jinhua Wang and Fei Ye. Their work appears in journals such as Biochemical Pharmacology, Clinical Cancer Research, Cancer Investigation, European Journal of Immunology and ImmunoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.